Bersama Mencapai Puncak Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bersama Mencapai Puncak Tbk. trades at Rp680 (market cap 777.97B, 15.52M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Bersama Mencapai Puncak Tbk. is far larger — about 2.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Bersama Mencapai Puncak Tbk. is more actively traded (15.52M versus 159.2K). Which is the better fit depends on your goals.
| BAIK | DGNS | |
|---|---|---|
Market Cap | 777.97B | 310.75B |
Volume | 15.52M | 159.2K |
Lot | 155.21K | 1.59K |
Turnover | 10.57B | 34.72M |
Average Price | 680.95 | 218.06 |
Value | 10.57B | 34.72M |
Indicative Equilibrium Price | 680 | 220 |
Indicative Equilibrium Volume | 783 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bersama Mencapai Puncak Tbk (the Company) was established based on Deed No. 8, dated February 7, 2018 made before Notary Robertus Radio Poetra, S.H., M.Kn. in Malang. The company started its commercial activities since 2018, by operating using the Ayam Goreng Nelongso and Nelongso trademarks.
Read more on BAIK →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →